Muscle up, waist down: exercise shifted both at once after 60

Sarcopenic obesity, the combination of low muscle mass and excess fat in the same body, hits older adults particularly hard because the two problems compound each other: weaker muscles make activity harder, and inactivity feeds further fat gain. The practical question is whether exercise can move both sides of the equation at once, and whether adding dietary supplements to exercise buys anything extra. This review deliberately targeted community-dwelling people aged 60 and over, the group most readers will recognise in themselves or their parents, rather than hospital patients, which makes its findings unusually relevant to everyday ageing.

The authors systematically searched five databases up to April 2018 for randomised controlled trials testing exercise alone or exercise combined with dietary supplements in people aged 60 and over with sarcopenic obesity, with interventions lasting at least six weeks. Nine papers reporting seven trials with a total of 558 participants made the cut. The primary outcomes were percentage of body fat mass, appendicular skeletal muscle mass and hand grip strength. Results were pooled as mean differences using random effects meta-analysis, and risk of bias was assessed with the Cochrane tool.

Exercise, with or without supplements, improved the muscle side of the ledger: grip strength rose by 1.30 kg, gait speed by 0.05 m/s and appendicular skeletal muscle mass by 0.40 kg. The fat side moved too, with waist circumference down by 1.40 cm, total fat mass down by 1.77 kg and trunk fat mass down by 0.82 kg. Every one of these shifts is modest in absolute terms, but they all pointed in the right direction simultaneously. The review could not cleanly separate which exercise regimes or which supplements did the work, and the authors call for better-designed trials to do exactly that.

This confirms the direction of travel in the sarcopenic obesity literature: structured exercise improves muscle-related outcomes and trims fat-related ones, even in people past 60. It sits alongside other reviews that have singled out resistance training as the most promising tool for the condition, though this analysis pooled exercise types together rather than ranking them. The open questions are the familiar ones: which regime, what dose, and whether supplements add anything beyond what training alone achieves. The authors explicitly note the need for trials that systematically compare different exercise regimes and dietary supplements in this population.

For anyone over 60, or watching a parent get there, this is a reason to see exercise as a tool that works on both problems of sarcopenic obesity at once, rather than a forced choice between building muscle and losing fat. The honest sizing matters: a gain of 1.30 kg in grip strength and a loss of 1.77 kg in fat mass are meaningful for health but will not transform a physique. What the evidence does not yet show is whether any supplement earns its place alongside the training. On these numbers, the training itself carries the result.